These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3597635)

  • 21. Comparative pharmacokinetic analysis of novel sustained-release dosage forms of pentoxifylline in healthy subjects.
    Raz I; Ben-David J; Hussein Z; Samara E
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):206-8. PubMed ID: 3403100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Investigations on the pharmacokinetics of pentoxifylline in chronic renal failure (authors transl)].
    Schaefer K; von Herrath D; Hensel A; Grigoleit HG
    Med Klin; 1977 Feb; 72(6):204-6. PubMed ID: 840136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of orally administered pentoxifylline in humans.
    Smith RV; Waller ES; Doluisio JT; Bauza MT; Puri SK; Ho I; Lassman HB
    J Pharm Sci; 1986 Jan; 75(1):47-52. PubMed ID: 3958905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of pentoxifylline and its metabolites in human plasma by high-performance liquid chromatography with solid-phase extraction.
    Mancinelli A; Pace S; Marzo A; Martelli EA; Passetti G
    J Chromatogr; 1992 Mar; 575(1):101-7. PubMed ID: 1517286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of intranasal and intratracheal pentoxifylline in rabbits.
    Adcock KG; Kyle PB; Deaton JS; Olivier JH; Hogan SM
    Pharmacotherapy; 2007 Feb; 27(2):200-6. PubMed ID: 17253910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteration of pentoxifylline pharmacokinetics by cimetidine.
    Mauro VF; Mauro LS; Hageman JH
    J Clin Pharmacol; 1988 Jul; 28(7):649-54. PubMed ID: 3216031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effectiveness of intravenous infusion treatment of peripheral arterial occlusive disease with Trental--results of a multicenter double-blind study].
    Rudofsky G; Haussler KF; Künkel HP; Schneider-May H; Spengel F; Symann O; Werner HJ; Rössner M
    Vasa Suppl; 1987; 20():375-8. PubMed ID: 3321494
    [No Abstract]   [Full Text] [Related]  

  • 28. Metabolism and pharmacokinetics of 14C-pentoxifylline in healthy volunteers.
    Bryce TA; Chamberlain J; Hillbeck D; Macdonald CM
    Arzneimittelforschung; 1989 Apr; 39(4):512-7. PubMed ID: 2751739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of pentoxifylline during concomitant theophylline administration to rats.
    Rocci ML; Luke DR; Saccar CL
    Pharm Res; 1987 Oct; 4(5):433-5. PubMed ID: 3508555
    [No Abstract]   [Full Text] [Related]  

  • 30. Interconversion and tissue distribution of pentoxifylline and lisofylline in mice.
    Wyska E; Pekala E; Szymura-Oleksiak J
    Chirality; 2006 Aug; 18(8):644-51. PubMed ID: 16721727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma levels of orally and subcutaneously administered pentoxifylline in rabbits.
    Hsu HY; Saadati HG; Mishra A; Heller KB; Sadun AA
    J Med; 2000; 31(3-4):149-66. PubMed ID: 11280447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The excretion of pentoxifylline and its metabolites into human breast milk.
    Witter FR; Smith RV
    Am J Obstet Gynecol; 1985 Apr; 151(8):1094-7. PubMed ID: 3985069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmacokinetics of oxpentifylline in man when administered by constant intravenous infusion.
    Ings RM; Nüdemberg F; Burrows JL; Bryce TA
    Eur J Clin Pharmacol; 1982; 23(6):539-43. PubMed ID: 7160423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug therapy in sensorineural hearing loss in childhood].
    Nickisch A; Heinemann M; Gross M
    Laryngol Rhinol Otol (Stuttg); 1987 Dec; 66(12):664-6. PubMed ID: 3431317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of oral or intravenous pentoxifylline on ocular and optic nerve blood flow.
    Jay WM; Aziz MZ; Chapman JM; Green K
    Ophthalmic Res; 1987; 19(6):318-21. PubMed ID: 3441353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of pentoxifylline and its major metabolites in microbial extracts by thin-layer and high-performance liquid chromatography.
    Smith RV; Yang SK; Davis PJ; Bauza MT
    J Chromatogr; 1983 Dec; 281():281-7. PubMed ID: 6668334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of peripheral gangrene due to systemic sclerosis with intravenous pentoxifylline.
    Goodfield MJ; Rowell NR
    Clin Exp Dermatol; 1989 Mar; 14(2):161-2. PubMed ID: 2598492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of sermion, Cavinton and trental in patients with cerebrovascular disorders].
    Lebedeva NV; Khrapova EV
    Sov Med; 1990; (1):60-3. PubMed ID: 2190329
    [No Abstract]   [Full Text] [Related]  

  • 39. [The onset of circulatory venous gangrene of the arm and its successful treatment by thrombolysis].
    Neugodov IuV; Sokolov GF; Popov VV; El'skaia IE
    Vestn Khir Im I I Grek; 1989 Nov; 143(11):60. PubMed ID: 2633440
    [No Abstract]   [Full Text] [Related]  

  • 40. [Detection and determination of 3,7-dimethyl-6-(5-oxo-hexoxy)-2H-purine-2-one, a byproduct of pentoxifylline synthesis].
    Proksa B; Michalák K; Nevydal J
    Pharmazie; 1984 Jun; 39(6):429-30. PubMed ID: 6483952
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.